MiR-33a suppresses breast cancer cell proliferation and metastasis by targeting ADAM9 and ROS1
详细信息 查看全文
- 作者：Chuankai Zhang ; Yunda Zhang ; Weiji Ding ; Yancheng Lin ; Zhengjie Huang…
- 关键词：miR ; 33a ; breast cancer ; proliferation ; metastasis
- 刊名：Protein & Cell
- 出版年：2015
- 出版时间：December 2015
- 年：2015
- 卷：6
- 期：12
- 页码：881-889
- 全文大小：1,343 KB
- 参考文献：Aleckovic M, Kang Y (2015) Regulation of cancer metastasis by cell-free miRNAs. Biochim Biophys Acta 1855:24鈥?2PubMed
Bergethon K, Shaw AT, Ou SH, Katayama R, Lovly CM, McDonald NT, Massion PP, Siwak-Tapp C, Gonzalez A, Fang R et al (2012) ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol 30:863鈥?70PubMedCentral CrossRef PubMed
Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ, Barbosa-Morais NL, Teschendorff AE, Green AR, Ellis IO et al (2007) MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 8:R214PubMedCentral CrossRef PubMed
Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331:1559鈥?564CrossRef PubMed
Fang X, Cai Y, Liu J, Wang Z, Wu Q, Zhang Z, Yang CJ, Yuan L, Ouyang G (2011) Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal. Oncogene 30:4707鈥?720CrossRef PubMed
Hong W, Dong E (2014) The past, present and future of breast cancer research in China. Cancer Lett 351:1鈥?CrossRef PubMed
Ibrahim AF, Weirauch U, Thomas M, Grunweller A, Hartmann RK, Aigner A (2011) MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res 71:5214鈥?224CrossRef PubMed
Li ZJ, Ou-Yang PH, Han XP (2014) Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells. Cell Signal 26:141鈥?48CrossRef PubMed
Liu AY, Cai Y, Mao Y, Lin Y, Zheng H, Wu T, Huang Y, Fang X, Lin S, Feng Q et al (2014) Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24. Carcinogenesis 35:537鈥?45CrossRef PubMed
Lu S, Azada MC, Ou SH (2015) Choroidal metastasis response to crizotinib in a ROS1-rearranged NSCLC patient. Lung Cancer 87:207鈥?09CrossRef PubMed
Marquart TJ, Allen RM, Ory DS, Baldan A (2010) miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci USA 107:12228鈥?2232PubMedCentral CrossRef PubMed
Micocci KC, Martin AC, Montenegro Cde F, Durante AC, Pouliot N, Cominetti MR, Selistre-de-Araujo HS (2013) ADAM9 silencing inhibits breast tumor cell invasion in vitro. Biochimie 95:1371鈥?378CrossRef PubMed
Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, Naar AM (2010) MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328:1566鈥?569CrossRef PubMed
O鈥橲hea C, McKie N, Buggy Y, Duggan C, Hill AD, McDermott E, O鈥橦iggins N, Duffy MJ (2003) Expression of ADAM-9 mRNA and protein in human breast cancer. Int J Cancer (Journal international du cancer) 105:754鈥?61CrossRef
Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ, Fernandez-Hernando C (2010) MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328:1570鈥?573PubMedCentral CrossRef PubMed
Rayner KJ, Esau CC, Hussain FN, McDaniel AL, Marshall SM, van Gils JM, Ray TD, Sheedy FJ, Goedeke L, Liu X et al (2011) Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 478:404鈥?07PubMedCentral CrossRef PubMed
Rocks N, Paulissen G, El Hour M, Quesada F, Crahay C, Gueders M, Foidart JM, Noel A, Cataldo D (2008) Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. Biochimie 90:369鈥?79CrossRef PubMed
Ruan K, Fang X, Ouyang G (2009) MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 285:116鈥?26CrossRef PubMed
Shaw AT, Ou SH, Bang YJ, Camidge DR, Solomon BJ, Salgia R, Riely GJ, Varella-Garcia M, Shapiro GI, Costa DB et al (2014) Crizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl J Med 371:1963鈥?971PubMedCentral CrossRef PubMed
Thomas M, Lange-Grunweller K, Weirauch U, Gutsch D, Aigner A, Grunweller A, Hartmann RK (2012) The proto-oncogene Pim-1 is a target of miR-33a. Oncogene 31:918鈥?28CrossRef PubMed
Volinia S, Galasso M, Sana ME, Wise TF, Palatini J, Huebner K, Croce CM (2012) Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. Proc Natl Acad Sci USA 109:3024鈥?029PubMedCentral CrossRef PubMed
Wan L, Pantel K, Kang Y (2013) Tumor metastasis: moving new biological insights into the clinic. Nat Med 19:1450鈥?464CrossRef PubMed
Wang Z, Ouyang G (2012) Periostin: a bridge between cancer stem cells and their metastatic niche. Cell Stem Cell 10:111鈥?12CrossRef PubMed
Wang H, Sun T, Hu J, Zhang R, Rao Y, Wang S, Chen R, McLendon RE, Friedman AH, Keir ST et al (2014) miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways. J Clin Investig 124:4489鈥?502PubMedCentral CrossRef PubMed
Zheng L, Baumann U, Reymond JL (2004) An efficient one-step site-directed and site-saturation mutagenesis protocol. Nucleic Acids Res 32:e115PubMedCentral CrossRef PubMed
Zhou Y, Huang Z, Wu S, Zang X, Liu M, Shi J (2014) miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST. J Exp Clin Cancer Res 33:12PubMedCentral CrossRef PubMed - 作者单位：Chuankai Zhang (1) (2)
Yunda Zhang (1) (2)
Weiji Ding (1) (3)
Yancheng Lin (2)
Zhengjie Huang (1) (3)
Qi Luo (1) (3)
1. Department of Gastrointestinal Surgery, First Affiliated Hospital of Xiamen University, Xiamen, 361003, China
2. State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, 361102, China
3. Department of Gastrointestinal Surgery, First Clinical Medical College of Fujian Medical University, Fuzhou, 350005, China - 刊物主题：Biochemistry, general; Protein Science; Cell Biology; Stem Cells; Human Genetics; Developmental Biology;
- 出版者：Springer Berlin Heidelberg
- ISSN：1674-8018
文摘